Comparison of low molecular weight hydroxyethyl starch and human albumin as priming solutions in children undergoing cardiac surgery

Perfusion (United Kingdom)

Volumn 29, Issue 5, 2014, Pages 462-468

  Miao, Na ^a   Yang, Jing ^a   Du, Zhongtao ^a   Liu, Wei ^a   Ni, Hong ^a   Xing, Jialin ^a   Yang, Xiaofang ^a   Xu, Bo ^a   Hou, Xiaotong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

cardiopulmonary bypass; colloid solution; pediatric; plasma colloid osmotic pressure; priming solution

Indexed keywords

CREATININE; GLUCOSE; HETASTARCH; HUMAN ALBUMIN; LACTIC ACID; GLUCOSE BLOOD LEVEL; HETASTARCH DERIVATIVE; PLASMA SUBSTITUTE; SERUM ALBUMIN;

ARTICLE; BLEEDING; BLOOD VOLUME; CARDIOPULMONARY BYPASS; CHILD; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; FEMALE; HEMATOCRIT; HEMODYNAMIC PARAMETERS; HUMAN; INFANT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; ONCOTIC PRESSURE; PLASMA VOLUME; PRESCHOOL CHILD; PRIORITY JOURNAL; BLOOD; CONTROLLED STUDY; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; HEART DEFECTS, CONGENITAL; METABOLISM; OSMOTIC PRESSURE; RANDOMIZED CONTROLLED TRIAL;

BLOOD GLUCOSE; CARDIOPULMONARY BYPASS; CREATININE; FEMALE; HEART DEFECTS, CONGENITAL; HEMATOCRIT; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; INFANT; LACTIC ACID; MALE; OSMOTIC PRESSURE; PLASMA SUBSTITUTES; SERUM ALBUMIN;

EID: 84929130579     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659114528267     Document Type: Article

References (29)

1. Shahbazi S, Zeighami A, Allahyary E. Effect of colloid versus crystalloid administration of cardiopulmonary bypass prime solution on tissue and organ perfusion. Iranian Cardiovascular Research Journal. 2011 ; 5: 24-31
2. Strunden MS, Heckel K, Goetz AE, et al. Perioperative fluid and volume management: physiological basis, tools and strategies. Ann Intensive Care. 2011 ; 1: 2
3. McIlroy DR, Kharasch ED. Acute intravascular volume expansion with rapidly administered crystalloid or colloid in the setting of moderate hypovolemia. Anesth Analg. 2003 ; 96: 1572-1577 (Pubitemid 36623108)
4. Tollofsrud S, Svennevig JL, Breivik H, et al. Fluid balance and pulmonary functions during and after coronary artery bypass surgery: Ringer's acetate compared with dextran, polygeline, or albumin. Acta Anaesthesiol Scand. 1995 ; 39: 671-677
5. Liu J, Ji B, Long C, et al. Which is the optimal option during pediatric cardiopulmonary bypass: high colloid oncotic pressure priming, ultrafiltration or both?. Eur J Cardiothorac Surg. 2011 ; 40: 772
6. Golab HD, Scohy TV, de Jong PL, et al. Relevance of colloid oncotic pressure regulation during neonatal and infant cardiopulmonary bypass: a prospective randomized study. Eur J Cardiothorac Surg. 2011 ; 39: 886-891
7. Cecere G, Groom R, Forest R, et al. A 10-year review of pediatric perfusion practice in North America. Perfusion. 2002 ; 17: 83-89 (Pubitemid 34262790)
8. Russell JA, Navickis RJ, Wilkes MM. Albumin versus crystalloid for pump priming in cardiac surgery: meta-analysis of controlled trials. J Cardiothorac Vasc Anesth. 2004 ; 18: 429-437
9. Standl T, Lochbuehler H, Galli C, et al. HES 130/0.4 (Voluven) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial. Eur J Anaesthesiol. 2008 ; 25: 437-445 (Pubitemid 351629970)
10. Ooi JS, Ramzisham AR, Zamrin MD. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery?. Asian Cardiovasc Thorac Ann. 2009 ; 17: 368-372
11. McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971 ; 285: 1441-1446
12. Sussmane JB, de Soto M, Torbati D. Plasma colloid osmotic pressure in healthy infants. Crit Care. 2001 ; 5: 261-264 (Pubitemid 32976333)
13. Aukerman J, Voepel-Lewis T, Riegger LQ, et al. The relationship between extracorporeal circuit prime, albumin, and postoperative weight gain in children. J Cardiothorac Vasc Anesth. 1998 ; 12: 408-414 (Pubitemid 28374199)
14. Akkucuk FG, Kanbak M, Ayhan B, et al. The effect of HES (130/0.4) usage as the priming solution on renal function in children undergoing cardiac surgery. Ren Fail. 2013 ; 35: 210-215
15. Ertmer C, Rehberg S, Van Aken H, et al. Relevance of non-albumin colloids in intensive care medicine. Best Pract Res Clin Anaesthesiol. 2009 ; 23: 193-212
16. Hartog CS, Bauer M, Reinhart K. The efficacy and safety of colloid resuscitation in the critically ill. Anesth Analg. 2011 ; 112: 156-164
17. Hanart C, Khalife M, De Ville A, et al. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4. Crit Care Med. 2009 ; 37: 696-701
18. Eising GP, Niemeyer M, Gunther T, et al. Does a hyperoncotic cardiopulmonary bypass prime affect extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery?. Eur J Cardiothorac Surg. 2001 ; 20: 282-289 (Pubitemid 32706609)
19. Mehlhorn U, Allen SJ, Davis KL, et al. Increasing the colloid osmotic pressure of cardiopulmonary bypass prime and normothermic blood cardioplegia minimizes myocardial oedema and prevents cardiac dysfunction. Cardiovasc Surg. 1998 ; 6: 274-281 (Pubitemid 28319764)
20. Tamayo E, Alvarez FJ, Alonso O, et al. The inflammatory response to colloids and crystalloids used for pump priming during cardiopulmonary bypass. Acta Anaesthesiol Scand. 2008 ; 52: 1204-1212
21. Cooper JR, Giesecke NM Cardiopulmonary Bypass: Principles and Practice. 2 nd ed.2003, Lippincott Williams & Wilkins, Philadelphia, PA, Ch 11. Gravlee GP Davis RF Kurusz M Uttle JR, ed. Philadelphia, PA: Lippincott Williams & Wilkins ; 2003 :
22. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008 ; 358: 125-139
23. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012 ; 367: 124-134
24. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012 ; 367: 1901-1911
25. Hunsicker O, Francis RC. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: how to guide fluid therapy?. Crit Care. 2012 ; 16: 464
26. Muller L, Jaber S, Molinari N, et al. Fluid management and risk factors for renal dysfunction in patients with severe sepsis and/or septic shock. Crit Care. 2012 ; 16: R34
27. Annane D, Siami S, Jaber S, et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA. 2013 ; 310: 1809-1817
28. Van der Linden P, De Ville A, Hofer A, et al. Six percent hydroxyethyl starch 130/0.4 (Voluven®) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients. Anesthesiology. 2013 ; 119: 1296-1309
29. Martin C, Jacob M, Vicaut E, et al. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology. 2013 ; 118: 387-394